Fonagy review shows autism and ADHD are significantly under-diagnosed
Figures show most neurodivergent individuals are still being missed.
Published 14 October 2026. Written by Dr Chris Worfolk.
Recently, Peter Fonagy and colleagues published their independent review into the prevalence and support for mental health conditions, ADHD and autism. In this article, we will explore some of the findings.
Understanding diagnosis rates
One of the things the review examined was whether autism and ADHD were being under-diagnosed or over-diagnosed.
However, to calculate this, we need to understand how many people are neurodivergent, so that we can calculate how many diagnoses we should be seeing.
One of the key findings of the review is that we do not have any up-to-date research on this in the UK, and the review calls for this research to be done. This is especially important because it needs to take into account everything we have learnt about internal presentations, masking, and autism in women and girls.
A previous UK estimate for autism, published nine years ago, was 1.2%. This is the figure the review suggests needs updating.
1.2% falls significantly behind international estimates. For example, South Korea estimate it at 2.6% (Kim et al., 2011) and the US at 3.2% according to the CDC (Shaw et al., 2025).
Therefore, we should be seeing diagnosis rates of around 3%, but that figure could again rise as we increase our understanding of autism.
Autism diagnosis in adults
The review shows that we are significantly under-diagnosing autism in adults.
This ranges based on the age group with 18-24 being diagnosed at around 2.5% while over 65s are diagnosed at 0.07%. Weighted by England's adult population, the figures suggest we are diagnosing autism in around 0.6% of adults.
This means that we are missing around four out of five autistic adults (80%). Even using the lower figure, that the review says needs updating, we're still missing half of autistic adults.
Autism diagnosis in children
Autism diagnosis in children is now higher at around 4%. This is above the 3% "expected" rate but it is important to be clear that the review does not say this is a result of over-diagnosis but recommends we should investigate further.
This is an area where over-diagnosis is a risk and we should be open to that possibility. However, we also need to consider that prevalence estimates have been revised upwards repeatedly: the CDC’s figure has gone from around 1 in 150 in 2000 to 1 in 31 today. The fastest area of growth has come from women and girls, which is what we would expect as we increase our understanding of internal presentations.
Is neurodivergence more common in younger people?
One explanation for the differences between age groups is that autism and ADHD have become more common. But the review makes it clear that it considers these levels stable, and that it is historic under-diagnosis that accounts for the change.
This in itself is worth considering.
The other key finding of the review is that mental distress is increasing and that this is not a result of young people being 'snowflakes' but rather that life is getting harder. The review names rising rates of insecurity, poverty, stress, and lack of rest and recovery as key drivers.
To meet the clinical threshold for autism or ADHD, you have to be disabled by it. As society makes life harder for individuals, we should expect more individuals to reach this threshold. Thus, prevalence, and therefore diagnostic rates should rise over time.
If this were the case, we would expect to see a rise as children move to secondary school, where demands on them increase sharply. And this is what we see: the review describes “a pronounced peak in recorded prevalence in Year 7 that was not evident a decade ago.”
Secondary school has always been a big step up, so what has changed? The review’s answer is that education has become more “continuously evaluative”, and “a more significant contributor to distress than for previous generations.” The step up is now steeper, and more children are reaching the point where their difficulties become disabling. Some of the peak will also reflect families seeking a diagnosis to secure support for the move, but that too tells us these children are struggling.
Prevalence of ADHD
Next, let us turn our attention to ADHD. NICE has published guidance on this which cites about 5% for children and young people and 3% for adults.
Again, though, we have to ask if these figures fully account for our increased understanding of ADHD. For example, Salari et al. (2023) concluded the prevalence was 7.6% in 3-12 year olds and 5.6% in 12-18 year olds.
ADHD diagnosis in adults
Based on the review's figures, we are currently diagnosing ADHD in adults at a rate of 1.1%, meaning we are identifying 37% of ADHD individuals and missing 63% of individuals. Therefore, we are under-diagnosing ADHD in adults by about two-thirds.
ADHD diagnosis in children
Based on the review's figures, we are currently diagnosing ADHD in children at a rate of 2.2%, meaning that we are identifying 45% of ADHD children and missing 55% of ADHD children. Therefore, we are under-diagnosing ADHD in children by about half.
Society is failing neurodivergent individuals
The review concludes that distress has increased in society and that this is not a result of people being "snowflakes" but rather that society has created distressing conditions.
Between 50% and 75% of people with autism or ADHD meet criteria for at least one common mental disorder. These rates are increasing and match the wider social picture that most people are now in more psychological distress than they were 20 years ago.
Everyone is suffering. But neurodivergent individuals are particularly suffering, to the point that most of those now meeting the screening criteria for autism or ADHD are in marked psychological distress.
Problems with Right To Choose
One area where the review does flag up issues is with Right To Choose providers potentially doing sloppy assessments.
This has already been documented by BBC Panorama. Some of these providers appeared to be highly motivated to sell people ADHD medication.
At Leeds Autism Practice, we conduct assessments over multiple hours and multiple sessions. It's a pain. But it is important to get the correct result. We would love to see a crackdown on rogue Right To Choose providers.
For balance, I have sometimes read reports written by Right To Choose providers that I thought were very comprehensive. Unfortunately, it seems to be a bit of a lottery at the minute.
Why are media talking about over-diagnosis?
Despite the review stating that it cannot conclude over-diagnosis is occurring at scale, and the figures showing we are still under-diagnosing, many media headlines seem drawn to over-diagnosis. For example:
- "Rush to diagnose ADHD and autism can damage children: As rates soar up to 40-fold, a major review warns of the toll on those wrongly given a label" (Daily Mail)
- “ADHD and autism at risk of over-diagnosis, says government review” (BBC)
- "ADHD surge fuelled by benefits, report warns" (The Telegraph)
- "ADHD label ‘risks lifelong harm to children’ as diagnoses surge" (The Times)
These headlines need to be placed in a context that Wes Streeting originally commissioned the review as part of a drive to reduce welfare spending.
This was entirely political in nature and not in line with the NHS's own findings. NHS England’s independent ADHD Taskforce said in April 2025 that “In England, clinician-defined ADHD is under-recognised, under-diagnosed and under-treated.”
Similarly, a research paper published in the British Journal of Psychiatry in March of this year found "There is no evidence that ADHD is over-diagnosed in the UK" (Cortese et al., 2026).
Talking about over-diagnosis might make a good headline, but it is not supported by the Fonagy review, NHS England's ADHD Taskforce, or peer-reviewed research.
Conclusion
Both autism and ADHD are significantly under-diagnosed. The figures show we are still missing more than half of autistic adults, and ADHD in both adults and children. Only diagnostic rates for autistic children reach or exceed the expected benchmark.
References
Cortese, S., Daley, D., Hollis, C., Rae, S., Ani, C., Asherson, P., ... & Ford, T. (2026). ADHD (over) diagnosis: fiction, fashion and failure. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2026.10546
Fonagy, P., Baird, G., & Wessely, S. (2026). Independent review into prevalence and support for mental health conditions, ADHD and autism: Final report. Department of Health and Social Care.
Kim, Y. S., Leventhal, B. L., Koh, Y. J., Fombonne, E., Laska, E., Lim, E. C., Cheon, K. A., Kim, S. J., Kim, Y. K., Lee, H., Song, D. H., & Grinker, R. R. (2011). Prevalence of autism spectrum disorders in a total population sample. The American journal of psychiatry, 168(9), 904–912. https://doi.org/10.1176/appi.ajp.2011.10101532
NHS England. (2025). Report of the independent ADHD Taskforce: Part 1.
Salari, N., Ghasemi, H., Abdoli, N., Rahmani, A., Shiri, M. H., Hashemian, A. H., Akbari, H., & Mohammadi, M. (2023). The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Italian journal of pediatrics, 49(1), 48. https://doi.org/10.1186/s13052-023-01456-1
Shaw, K. A., Williams, S., Patrick, M. E., Valencia-Prado, M., Durkin, M. S., Howerton, E. M., Ladd-Acosta, C. M., Pas, E. T., Bakian, A. V., Bartholomew, P., Nieves-Muñoz, N., Sidwell, K., Alford, A., Bilder, D. A., DiRienzo, M., Fitzgerald, R. T., Furnier, S. M., Hudson, A. E., Pokoski, O. M., . . . Maenner, M. J. (2025). Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years — Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveillance Summaries, 74(2), 1–22. https://doi.org/10.15585/mmwr.ss7402a1